









Department of Obstetrics and Gynaecology  
Groote Schuur Hospital 
University of Cape Town 
Masters of Medicine dissertation for candidate 
Barend HJ Botha 
Student number BTHBAR004 
 
Systematic review: Availability, effectiveness 
and safety of assisted reproductive 























The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 





Systematic review: Availability, effectiveness and safety of assisted reproductive 
techniques in Sub-Saharan Africa 
Table of Contents   
1. Declaration  
2. Abstract 
3. Acknowledgements 
4. List of tables 
5. List of figures 
6. Abbreviations 





Systematic review: Availability, effectiveness and safety of assisted reproductive 
techniques in Sub-Saharan Africa 
Declaration 
The research reported in this document is independent work (except where 
acknowledgments indicate otherwise) performed by the candidate, Barend Hendrik 
Jacobus Botha, for the purpose of obtaining a Masters of Medicine degree at the 
University of Cape Town, and has neither been submitted in part or fully to any 
other University.  
This work has been submitted and accepted for publication prior to submission for 
above mentioned degree but has not been submitted for any other degree 
programs. 
A protocol for this research has been registered at PROSPERO with registration 
number CRD42016032336. 
No external funding was used for the purpose of this research. 




Systematic review: Availability, effectiveness and safety of assisted reproductive 
techniques in Sub-Saharan Africa 
Abstract 
 
STUDY QUESTION: What is the evidence pertaining to availability, effectiveness 
and safety of assisted reproductive technology (ART) in sub-Saharan Africa?  
SUMMARY ANSWER: According to overall limited and heterogeneous evidence, 
availability and utilization of ART are very low, clinical pregnancy rates largely 
compare to other regions but are accompanied by high multiple pregnancy rates, 
and in the near absence of data on deliveries and live births the true degree of 
effectiveness and safety remains to be established.  
WHAT IS KNOWN ALREADY: In most world regions, availability, utilization and 
outcomes of ART are monitored and reported by national and regional ART 
registries. In sub-Saharan Africa there is only one national and no regional registry 
to date, raising the question what other evidence exists documenting the status of 
ART in this region.  
STUDY DESIGN, SIZE, DURATION: A systematic review was conducted 
searching PUBMED, SCOPUS, AFRICAWIDE, WEB OF SCIENCE and CINAHL 
databases from January 2000 to June 2017. A total of 29 studies were included in 
the review. The extracted data were not suitable for meta-analysis.  
PARTICIPANTS/MATERIALS, SETTING, METHOD:  The review was conducted 
according to PRISMA guidelines. All peer-reviewed manuscripts irrespective of 
language or study design that presented original data pertaining to availability, 
effectiveness and safety of ART in sub-Saharan Africa were eligible for inclusion. 
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reviewed studies for possible inclusion and critically appraised selected 
manuscripts. Data were analyzed descriptively, being unsuitable for statistical 
analysis.  
MAIN RESULTS AND THE ROLE OF CHANCE:  The search yielded 810 
references of which 29 were included based on the predefined selection and 
eligibility criteria. Extracted data came from 23 single centre observational studies, 
2 global ART reports, 2 reviews, 1 national data registry and 1 community-based 
study. ART services were available in 10 countries and delivered by 80 centres in 6 
of these. Data pertaining to number of procedures existed from 3 countries totaling 
4619 fresh non-donor aspirations in 2010. The most prominent barrier to access 
was cost. Clinical pregnancy rates ranged between 21.2% to 43.9% per embryo 
transfer but information on deliveries and live births were lacking, seriously limiting 
evaluation of ART effectiveness. When documented, the rate of multiple pregnancy 
was high with information on outcomes similarly lacking.  
LIMITATIONS, REASONS FOR CAUTION: The findings in this review are based 
on limited data from a limited number of countries, and are derived from 
heterogeneous studies, both in terms of study design and quality, many of which 
include small sample sizes. Although representing best available evidence, this 
requires careful interpretation regarding the degree of representativeness of the 
current status of ART in sub-Saharan Africa.  
WIDER IMPLICATIONS OF THE FINDINGS: The true extent and outcome of ART 
in sub-Saharan Africa could not be reliably documented as the relevant information 
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registry in order to report and monitor availability, effectiveness and safety of ART 
thus contributing to evidence-based practice and possible development strategies.  
STUDY FUNDING/COMPETING INTEREST(S):  No funding was received for this 
study. The authors had no competing interests.  
TRIAL REGISTRATION NUMBER: PROSPERO CRD42016032336  
KEY WORDS: assisted reproductive technology / availability / IVF outcome / 
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STUDY QUESTION:What is the evidence pertaining to availability, effectiveness and safety of ART in sub-Saharan Africa?
SUMMARY ANSWER: According to overall limited and heterogeneous evidence, availability and utilization of ART are very low, clinical
pregnancy rates largely compare to other regions but are accompanied by high multiple pregnancy rates, and in the near absence of data on
deliveries and live births the true degree of effectiveness and safety remains to be established.
WHAT IS KNOWN ALREADY: In most world regions, availability, utilization and outcomes of ART are monitored and reported by
national and regional ART registries. In sub-Saharan Africa there is only one national and no regional registry to date, raising the question
what other evidence exists documenting the status of ART in this region.
STUDY DESIGN, SIZE, DURATION: A systematic review was conducted searching Pubmed, Scopus, Africawide, Web Of Science and
CINAHL databases from January 2000 to June 2017. A total of 29 studies were included in the review. The extracted data were not suitable
for meta-analysis.
PARTICIPANTS/MATERIALS, SETTING, METHODS: The review was conducted according to Preferred Reporting Items for
Systematic Reviews (PRISMA) guidelines. All peer-reviewed manuscripts irrespective of language or study design that presented original data
pertaining to availability, effectiveness and safety of ART in sub-Saharan Africa were eligible for inclusion. Selection criteria were specified
prior to the search. Two authors independently reviewed studies for possible inclusion and critically appraised selected manuscripts. Data
were analysed descriptively, being unsuitable for statistical analysis.
MAIN RESULTS AND THE ROLE OF CHANCE: The search yielded 810 references of which 29 were included based on the prede-
fined selection and eligibility criteria. Extracted data came from 23 single centre observational studies, two global ART reports, two reviews,
one national data registry and one community-based study. ART services were available in 10 countries and delivered by 80 centres in six of
these. Data pertaining to number of procedures existed from three countries totalling 4619 fresh non-donor aspirations in 2010. The most
prominent barrier to access was cost. Clinical pregnancy rates ranged between 21.2% and 43.9% per embryo transfer but information on
deliveries and live births were lacking, seriously limiting evaluation of ART effectiveness. When documented, the rate of multiple pregnancy
was high with information on outcomes similarly lacking.
LIMITATIONS, REASONS FOR CAUTION: The findings in this review are based on limited data from a limited number of countries,
and are derived from heterogeneous studies, both in terms of study design and quality, many of which include small sample sizes. Although
representing best available evidence, this requires careful interpretation regarding the degree of representativeness of the current status of
ART in sub-Saharan Africa.
WIDER IMPLICATIONS OF THE FINDINGS: The true extent and outcome of ART in sub-Saharan Africa could not be reliably docu-
mented as the relevant information was not available. Current efforts are underway to establish a regional ART data registry in order to
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits
non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
report and monitor availability, effectiveness and safety of ART thus contributing to evidence-based practice and possible development
strategies.
STUDY FUNDING/COMPETING INTERESTS: No funding was received for this study. The authors had no competing interests.
TRIAL REGISTRATION NUMBER: PROSPERO CRD42016032336
Key words: ART / availability / IVF/ICSI outcome / infertility / sub-Saharan Africa / registry
Introduction
Infertility is a disease that affects the reproductive health of many mil-
lions of women and men worldwide and erodes their human right to
have a family. A review of current regulatory arrangements for ART in
European countries stated that to combat this pandemic required
both prevention and ART (Gianaroli et al., 2016). The importance of
prevention is arguably nowhere greater than in sub-Saharan Africa
where preventable causes of infertility are common and resources for
interventions are limited. Despite limited resources, the need for ART
is equally undisputable. Firstly, ART is one of the most effective infertil-
ity interventions and the only one that can overcome severe tubal and
male factor infertility. In addition, access to and availability of ART has
been shown to reduce the social stigma of infertility which is highly
prevalent in Africa (Inhorn and Patrizio, 2015).
ART export to Africa started in the early 1980s and continues to
expand both within and between countries. Although the extent of
this expansion is poorly documented, it seems to fall well short of the
need for ART according to a recent review of global infertility and
reproductive technologies (Inhorn and Patrizio, 2015). ART export to
Africa has also not been accompanied by the development of data
registries, which monitor and report utilization and outcomes in most
world regions. In the absence of systematically collected data on avail-
ability, effectiveness and safety it is in turn difficult to ascertain the
scope, practice and success of ART in sub-Saharan Africa.
To narrow this information gap, or alternatively to document its
size, we conducted a systematic review on ART in sub-Saharan Africa.
We searched for peer-reviewed papers that satisfied the following
PICOS requirements: women and/or infertile women/couples acces-
sing gynaecological or specialized infertility services, or health care pro-
viders who practiced or referred patients for ART (Participants); ART
(Intervention); no or any comparison with a reference or control
group (Comparisons); any information on availability, effectiveness and
safety (Outcomes); and any qualitative or quantitative study design
that presented or included original data (Study design). With the
exception of ART, these criteria were purposefully broad in order to
maximize data capture.
Materials andMethods
Following protocol registration with PROSPERO (Registration number
CRD42016032336), a systematic review was conducted according to
Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines.
No approval from the Institutional Research Ethics Committee was
sought as the study did not involve contact with patients or their
records.
Selection criteria
Selection criteria were established prior to the search. Articles that satis-
fied the above PICOS criteria were included using the following indicators
for outcomes:
- Availability: expressed quantitatively as number of ART centres or cycles
in a country or region; or qualitatively describing the presence of ART ser-
vices, settings (public, academic or private), their accessibility, referral
pathways and funding.
- Effectiveness: expressed quantitatively as singleton live birth delivery rates
or pregnancy, delivery or birth rates per cycle initiated, aspiration, embryo
transfer or woman; or qualitatively describing ART success.
- Safety: expressed quantitatively as rates of multiple pregnancies, deliver-
ies or births; stimulation and procedure-related complications, and mater-
nal/neonatal complications; or qualitatively describing safety, risks and risk
management of ART.
Where applicable, the definition of outcome measures was based on the
International Glossary of Infertility and Fertility Care (Zegers-Hochschild
et al., 2017).
Search strategy
We searched Pubmed, Scopus, AfricaWide, Web of Science and CINAHL
databases with the assistance of a trained medical librarian. The prese-
lected MeSH and keywords words were: sub-Saharan Africa, including
MeSH terms for specific countries and regions; outcome plus keywords for
clinical efficacy, treatment efficacy, availability and available, access, access-
ibility, treatment outcomes; as well as Reproductive Techniques, Assisted,
Fertilization in Vitro, Assisted Reproductive Technique, assisted repro-
ductive techniques, assisted reproductive technology, embryo transfer, sin-
gle embryo transfer, intracytoplasmic sperm injections, in vitro oocyte
maturation techniques, assisted reproductive technologies, fertilization
in vitro, gamete intrafallopian transfer. All titles and abstracts identified by
the search and published between 2000 and June 2017 were screened and
relevant papers retrieved in full text. These were scrutinized for additional
keywords and index terms which were added to the search strategy. The
reference list of all included papers was evaluated for further publications.
Lastly, articles that cited manuscripts selected for the review were
screened for possible inclusion.
Study eligibility
All peer reviewed papers regardless of language and study design that pro-
vided original data on the predefined selection criteria as well as systematic
reviews that included such data were eligible for inclusion. Publications
prior to 2000 were excluded in order to capture relatively recent informa-
tion. We also excluded laboratory-based studies that provided intermedi-
ary measures of effectiveness such as fertilization rates without stating
pregnancy rates; non-systematic reviews because of the risk of selection
bias after searching their references for eligible studies; and opinion-based
papers, reports without original data, theses, and other ‘grey literature’.
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Study selection was conducted independently by two reviewers (BB and
SD) with disagreement resolved by consensus. No attempt was made to
contact authors for additional information.
Data extraction
A standardized critical appraisal and data extraction tool was generated
for each of the different study designs (observational studies, system-
atic reviews, RCTs) using criteria from CASP (Critical Appraisal Skills
Programme) and statements from CONSORT (Consolidated Standards of
Reporting Trials), PRISMA, STARD (Standards for Reporting Diagnostic
accuracy studies), MOOSE (Guidelines for Meta-Analyses and Systematic
Reviews of Observational Studies) and STROBE (Strengthening The
Reporting of Observational Studies in Epidemiology) as appropriate. Two
reviewers independently appraised the articles and extracted data (BB and
SD; as well as BB and DS for papers authored by SD). Results were com-
pared and differences resolved by consensus.
Risk of bias
To reduce selection bias, the abstracts and full text papers were evaluated
by masking the authors as far as possible and by basing decisions regarding
relevance and eligibility on the independent appraisal by two reviewers.
Bias in studies included was assessed independently by the two reviewers
through use of the predesigned critical appraisal tool.
Data analysis
The included articles contained highly diverse settings and findings which
did not allow for combination or comparison by statistical means and were
amenable to descriptive analysis only. Studies were grouped by outcome
measures differentiating between quantitative and qualitative information.
Some studies provided quantitative results related to effectiveness and
safety of ART that were generated according to different study criteria to
the ones set out in this review while at the same time providing sufficient
information to re-calculate outcomes in keeping with those applied here.
These results are marked with a footnote in the relevant tables.
Results
Study selection
The initial search revealed 793 non-duplicate citations. All abstracts
were screened and 715 were excluded. Seventeen additional papers
were included: 15 from reference search and two manuscripts not
meeting the search criteria but based on their global significance and
relevance to the review. The citation search yielded no additional
entries. Ninety-five full text manuscripts were reviewed of which 62
were excluded with reason (Fig. 1). Four papers were subsequently
withdrawn from the analysis since upon close scrutiny no relevant
information could be extracted. This left 29 manuscripts for final inclu-
sion. The initial search yielded publications in English and French only,
and all included manuscripts were in English.
Characteristics of included studies
Tables I and II provide an overview of the charactersitics of included
studies. Seventeen studies originated from Nigeria, eight from South
Africa, two from Kenya, and one each from Rwanda and the
Netherlands (review). The two global surveys had no country of origin.
There were 21 cohort studies of which four were propsective, seven
retrospective, eight cross sectional, and two case–control. The
remainder study designs included RCT (n = 1), systematic review
(n = 1), registry data (n = 2), survey (n = 2), case report (n = 1),
and letter to the editor (n = 1). In 24 manuscripts, ART was the
primary focus. The remaining five papers addressed infertility more
generally with ART included (Adeyemi et al., 2009; Gerrits and
Shaw, 2010; Dhont et al., 2011; Adegbola and Akindele, 2013; Menuba
et al., 2014). Information on the specified outcomes of availability,
effectiveness and safety was provided by 21, 15 and 20 manuscripts,
respectively (Table I).
The World Report of the International Committee Monitoring ART
(ICMART) presented global registry data pertaining to ART utilization
and outcomes in 2008, 2009 and 2010 (Dyer et al., 2016). Only data
from the most recent year (2010) were included in this review. The
paper presenting registry data from South Africa reported summary
data on a few outcome indicators for 2009 which were submitted vol-
untarily by 12 of 18 ART centres (Dyer and Kruger, 2012). The
Surveillance of the International Federation of Fertility Societies (IFFS)
provided global survey data on ART availability and safety as well as
extensive information on ART practices (Ory et al., 2016). The survey
by Giwa-Osagie (2002) comprised original information through per-
sonal enquiry together with scientific studies and grey literature on
ART in sub-Saharan Africa but excluding South Africa. The systematic
review by Gerrits and Shaw (2010) comprised peer-reviewed English
language publications idenitifed via Pubmed, included years not being
stipulated, on psycho-social or cultural information pertaining to infer-
tility or infertility care in sub-Saharan Africa.
Risk of bias and study quality
All included manuscripts were evaluated vis-à-vis the criteria specified
in the critical appraisal tool. Specifically, a percentage score of number
of criteria satisfied in the data extraction tool was generated.
Manuscripts were rated as medium quality if the score was 50–65%
(n = 14) or as high (>65%; n = 7) and low quality (<50%; n = 8) as
agreed by the reviewers.
Availability
Number of countries, centres and cycles
Quantitative information pertaining to ART availability and utilization
(e.g. annual number of procedures) is summarized in Table III. The
number of ART cycles included in the studies, where applicable, is cap-
tured in Table I. According to qualitative data, the number of private
ART clinics was slowly increasing in some countries, but these facilities
were largely unavailable to rural communities (Giwa-Osagie, 2002;
Gerrits and Shaw, 2010; Okwelogu et al., 2012).
Public-sector facilities
Availability of ART in public sector facilities was scant. In the six coun-
tries that participated in the IFFS Surveillance, only seven of 80 ART
facilities were outside the private health sector: six in university hospi-
tals (public or private) and one in a public hospital (Ory et al., 2016). A
review on biomedical infertility care in sub-Saharan Africa concluded
that whilst some sort of infertility care was offered in public health care
systems, it was often unco-ordinated and rarely included ART (Gerrits
and Shaw, 2010). Similarly, three papers described that public-sector
care in Nigeria and Kenya had some capacity for infertility investiga-
tions but no or few options for treatment (Giwa-Osagie, 2002;
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Murage et al., 2011; Menuba et al., 2014). Discrepant access to treat-
ment was documented in a retrospective review conducted at a
gynaecological outpatient clinic in Nigeria (Adeyemi et al., 2009).
Although infertility was the commonest diagnosis (48.1%), it was sig-
nificantly less likely to result in treatment compared to other gynaeco-
logical conditions.
Barriers
Cost was the most frequently cited barrier (Gerrits and Shaw, 2010;
Jegede and Fayemiwo, 2010; Okohue et al., 2010b; Adesiyun, 2011;
Murage et al., 2011; Dyer and Kruger, 2012; Orhue et al., 2012;
Adegbola and Akindele, 2013; Dyer et al., 2013; Adenike et al., 2014;
Menuba et al., 2014). Only Kenya reported the presence of regulations
for ART reimbursement in the IFFS surveillance (Ory et al., 2016).
Describing a grant-based introduction of ART in a public-academic hos-
pital in Nigeria, Orhue et al. (2012) documented a cost of 3000USD for
good responders, which prevented many couples from undergoing ART
or undergoing more than 1 cycle. Higher costs for one private ART
cycle were described by the authors: 4000–5000USD in Nigeria and
Mali, and 3500USD in Uganda. The cost of one cycle in Ghana was
reported as equivalent to a nurse’s salary over 18 months (Gerrits and
Shaw, 2010). The large discrepancy between ART cost and average
household income was also discussed qualitatively (Giwa-Osagie,
2002; Gerrits and Shaw, 2010; Okohue et al., 2010b). The concern was
expressed that even a dramatic cost reduction would still keep ART out
of reach for most people, especially in countries where more than 70%
of the population lived below the poverty line (Giwa-Osagie, 2002).
One study from South Africa explored out-of-pocket co-payment
among 135 couples undergoing one ART cycle with conventional ovar-
ian stimulation at a public-academic institution (Dyer et al., 2013). All
couples used multiple financial coping strategies to offset the impact,
which created catastrophic expenditure, defined as out-of-pocket pay-
ment exceeding 40% of the annual non-food household expenditure,
for 22% of all households and for 51% among the poorest third.
Several papers referred to geographical barriers affecting people in
countries with no or limited ART services as well as people in rural
communities (Giwa-Osagie, 2002; Gerrits and Shaw, 2010; Dhont
et al., 2011; Murage et al., 2011; Okwelogu et al., 2012).
According to the IFFS surveillance, in Cameroon, Mali and Senegal
ART was only accessible to heterosexual, married couples. Nigeria
also offered ART to single women but not others in non-traditional








































(n = 95 [78+17])
62 Full-text articles excluded
18 published before 2000
12 opinion paper/commentary
8 not pertaining to region
7 reviews, not systematic, narrative
4 infertility, not ART
3 case reports
3 HIV not infertility
2 unable to obtain full-text
2 no data on outcomes
2 andrology papers
1 newsletter
33 studies included in data
extraction and critical
appraisal











15 Articles obtained from
screening references of
full-text articles
4 Articles excluded during data extraction
and critical appraisal
4 not reporting on outcomes
2 Articles included based
on global significance and
relevance
Figure 1 Flow chart of the systematic review of ART in sub-Saharan Africa.
4 Botha et al.
................................................
.............................................................................................................................................................................................
Table I Summary of peer-reveiwed papers published from January 2000 to June 2017 included in the review of ART in





Setting Study population/Sample size Outcomes reported
Availability Effectiveness Safety




NA Data from Cameroon, Mali, South Africa x x x










NA 68 publications x x x
Giwa-Osagie
(2002)
Survey (L) NA ART practitioners from 10 countries. x x x









Private ART centre 362 initiated fresh IVF cycles x x x














250 women attending GOC x
Adesiyun (2011) Letter to Editor
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Private hospital 52 ART pregnancies in 48 women x x x






Community setting 23 informants from diverse background incl




Private ART centre 452 aspirations with ≥ one oocyte x x














298 women < 36 y x x x
276 fresh non-donor ET
Okohue (2010a) Case report
(M)


























University hospital 600 fresh non-donor ART cycles x x x
504 fresh embryo transfers
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relationship structures (Ory et al., 2016). In contrast, two papers from
Nigeria reported that the majority of surveyed infertility specialists
(n = 102) opposed the use of ART in single women and that such prac-
tice contravened societal norms (Adesiyun, 2011; Ajayi and Dibosa-
Osadolor, 2013).
Two surveys explored ART knowledge and acceptability among 250
women attending general gynaecological clinics and 500 women attend-
ing infertility clinics in Nigeria (Okwelogu et al., 2012; Adenike et al.,
2014). Knowledge of ART existence was 37.2% and 46% with an
acceptability among those aware of ART of 37.6% and 73.5%, respect-
ively. Cost and religious reasons were the most prominent barriers, fol-
lowed by the belief that ART babies were socially unacceptable or
‘abnormal’. These results are aligned with qualitative data from Nigeria
which highlighted that, according to a variety of informants, ART was
against religion and interfered with concepts of paternity, hence offspring
would be discriminated against by both kin and community (Jegede and
Fayemiwo, 2010). Gerrits and Shaw (2010) concluded that little was
known about consumer ART acceptability in sub-Saharan Africa.
Lastly, the role of the male partner in facilitating or preventing access
was identified. According to qualitative data from Nigeria, women had
no financial or decision-making autonomy regarding use of ART
(Jegede and Fayemiwo, 2010). The importance but lack of male
involvement was also reported by Gerrits and Shaw (2010). Reasons
were diverse and included conceptualizing infertility as a female condi-
tion, polygamy, cultural barriers to semen analysis, fear of diagnosis of
male factor infertility, and health system failure to include men.
Effectiveness
Fourteen studies provided data pertaining to the effectiveness of ART
(Table IV). With one exception (Abels et al., 2007), ovarian
stimulation was conventional or not stipulated (n = 4). Different indi-
cators were used, the most frequent being clinical pregnancy rate
(CPR) per embryo transfer (ET) which ranged from 19.3% to 43.9%.
The ICMART World Report documented a mean CPR per aspiration
for fresh IVF and ICSI in sub-Saharan Africa of 31.3% in 2010 (Dyer
et al., 2016). The concomitant delivery rate (DR) was 20.8% in
Cameroon and not assessed in Mali and South Africa. Together, these
three countries reported 1445 pregnancies with pregnancy outcome
data for only 39 of these (Dyer et al., 2016). Only two other studies
provided delivery data, documenting a DR per fresh non-donor ET of
16.2% (Orhue et al., 2012) and a cumulative live birth DR of 14.4% per
initiated cycle with fresh and frozen ETs (Noreh et al., 2009).
Qualitative review data referred to ART pregnancy rates around
21% per ET with a ‘take home baby rate’ of 15% (Giwa-Osagie, 2002;
Gerrits and Shaw, 2010).
Safety
Twelve manuscripts provided information on the number of embryos
transferred. According to the ICMARTWorld Report, the mean num-
ber of embryos transferred in sub-Saharan Africa in fresh non-donor
IVF and ICSI cycles was 2.31 in 2010. This number was, however,
derived from only two countries (Cameroon and South Africa) and
fewer than 4000 ETs (Dyer et al., 2016). Data from the South African
registry, when calculated for the purpose of this review, yielded the
same number in 2009 (Dyer and Kruger, 2012). In three studies from
Nigeria and Kenya, the mean number of embryos transferred ranged
between 2.9 and 3.2 with no upper limit specified (Noreh et al., 2009;
Okohue et al., 2009, 2013). Patient and doctor preference for the
transfer of multiple embryos was reported by three studies (Okohue

















85 women x x






Private ART centre 82 couples with female partners < 38 y and
≥5 oocytes/aspiration
x x






























Not specified 142 aspiration cycles with ≥ one oocytes;
fertilisation by ICSI with testicular extracted
sperm
x
ET, embryo transfer; GIFT, gamete intrafallopian transfer; GOC, gynaecology outpatient clinic; H, high quality; low quality; M, medium quality; No., number.
aNot adherent to PRISMA guidelines.
bTemporary infertility clinic in a research setting.
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Global Dyer et al. (2016) Retrospective summary data of ART utilization,
effectiveness and safety stratefied by countries and world
regions.
In 2010, mean ART utilization in sub-Saharan Africa was 87 cycles/
million population/annum; mean fresh non-donor CPR/asp was
31.3%; near absence of data pertaining to deliveries, births and
multiple pregnancies.
Ory et al. (2016) Global data on ART availability, regulation and practice
stratefied by countries.
Limited number of ART centres; ART largely unregulated; near






Systematic reviewa evaluating infertility services with
focus on counselling, male involvement and ART
availability/acceptability.
Weak infertility services in public sector. ART acceptable but
mostly located in private sector and unavailable/unaffordable for




Survey complemented by published scientific data and
information from site visits and media.
ART services in six countries, largely unregulated, sustainable only
in the private sector. Collaborations with non-African centres.
Fresh non-donor PR/ET 21%, MPR 14.3–36% (data from three
centres).
Kenya Murage et al.
(2011)
Online survey to determine frequency of consultations
for infertility and access to ART.
Response rate 25.0% (n = 47). Infertility accounted for 1:4 of
gynaecological consultations. 50.3% due to tubal factor, 14.8% due
to male factor. Three ART centres. Access severely limited due to
cost and treatment capacity.
Noreh et al.
(2009)




Retrospective evaluation of 264 couples followed up for
24–48/12, of which 90 were fully investigated, including
characteristics, diagnosis and occurrence of pregnancy.
Infertility prevalence 26.8%. Female factor 37.8%, male factor
11.1%, combined factor 40.0%, unexplained 11.1%. Two couples
referred for ART with outcome not specified. Non-ART treatment
not further specified. PR/couple 4.9%, spontaneous versus
treatment-related pregnancies not specified.
Adenike et al.
(2014)
Administered questionnaires to determine infertility
prevalence, and knowledge and acceptability of ART.
40.8% of women presented with infertility, 46.0% aware of ART of
whom 73.5% would accept ART if required. Higher educational
status, being married, and longer duration of infertility predictors of
ART awareness and acceptability.
Adesiyun (2011) Description of patient characteristics and treatment
outcome in couples.
Indication for ART female (n = 7), male (n = 5) and combined
factor (n = 11). Nine couples underwent ART with nine
pregnancies in seven couples resulting in 13 live births.
Adeyemi et al.
(2009)
Case note review to determine pattern of gynaecological
consultations, investigations and treatment.
48.1% of women presented with infertility; 60.1% did not receive
definite treatment. Infertility associated with higher odds for no
treatment versus other conditions (OR 6.0; 2.99–12.05). ART only
available in private sector at high cost.
Ajayi and Dibosa-
Osadolor (2013)
Questionnaire survey to determine opinions re ethical
issues in ART.
Majority of respondents considered ART services necessary (99%),
supported egg and sperm donation (84.3% and 80.4%) as well as
surrogacy (82.4%), favoured transfer of > 3 embryos (78.4%) and




Case note review of pregnancy and neonatal outcome in
ART and non-ART pregnancies.
More adverse outcomes in ART pregnancies vs controls (30.8% vs
12.6%) including MPRs (17.3% vs 4.3%), preterm delivery (23.1% vs
4.8%) and low birthweight (13.5% vs 2.5%).
Jegede and
Fayemiwo (2010)
In-depth interviews to elicit cultural and ethical
challenges of ART.
Main barriers to ART lack of female decision-making power,
perceived risk (foetal abnormality, lack of social acceptance),
religious reasons and cost of treatment.
Melie (2003) Retrospective review of ART outcome stratified by
number of oocytes retrieved.
Four groups by number of oocytes after conventional ovarian
stimulation (1–5; 6–10; 11–15; >15). Significantly lower PRs with
<6 oocytes, no difference between other groups. CPR/asp 19.7%b,
c and CPR/ET 21.1%b,c.
Menuba et al.
(2014)
Prospective evaluation of infertile couples including
characteristics, investigations, recommended treatment,
and outcomes following non-ART interventions.
Infertility prevalence 12.1%. Female factor 32.1%, male factor
26.1%, combined factor 29.4%, unexplained 12.4%. CPR/couple
after non-ART treatment 12.8%b. 47 couples (21.6%) required
ART but unable to access.
Continued
7ART in sub-Saharan Africa
Information on the rate of multiple pregnancies was provided in
seven papers (Table IV). The majority documented a rate ≥20%
although the range was wide (12.5–44.4%). The rate of triplet preg-
nancies ranged from 4.0% to 14.5% (Noreh et al., 2009; Adesiyun,
2011; Oloyede et al., 2012; Orhue et al., 2012; Bosman et al., 2015);
that of miscarriages from 11.8% to 22.2% per clinical pregnancy (Abels
et al., 2007; Ezechi et al., 2008; Noreh et al., 2009; Okohue et al.,








Prospective evaluation of ART outcome stratified by
endometrial thickness.
Significantly higher CPR in women with endometrial thickness
7–14 mm compared to <7 mm or >14 mm. Centres conducted
±75 cycles/month.
Okohue (2010a) Case studies. 64 clinical pregnancies after ART over 3 yrs. Of these, presentation
and outcome of five ectopic pregnancies reported.
Okohue (2010b) Questionnaire-based interviews to determine preference
for number of embryos transferred.
After patient education on risk of multiple pregnancies, the number
of women choosing transfer of 1, 2 and 3 embryos was 3(5.6%), 36




Case note review to determine outcome of fresh IVF in
women with PCOS and tubal factor infertility.
Lower fertilization rates, higher risk of OHSS, but comparable CPR
and miscarriage rates in women with PCOS (n = 30) vs tubal
infertility (n = 42).
Okwelogu et al.
(2012)
Questionnaire-based interviews to determine awareness
and perceptions of ART.
40.4% of participants had tertiary and 52.8% secondary education.
312 women (62.4%) had not heard of ART. Of the other 188
women, 118 (62.8%) would reject ART because babies perceived
to be abnormal (n = 94) or treatment cost (n = 15). Of those in
favour of ART (n = 70), 64 women desired multiple pregnancies.
Oloyede et al.
(2012)
Case note review to determine frequency of
spontaneous foetal reduction in multiple pregnancies.
MPR 34.5% (19/55) with 11 twin, six triplet and two quadruplet
pregnancies. Spontaneous reduction in 47.7% of multiples. Average
of three embryos transferred.
Orhue et al.
(2012)
Case note review to determine outcomes of ART. CPR 30.0%, MPR 20.0%b. Up to three embryos/transfer. Public
ART feasible with WHO grant. Cost for good responders
3000USD/cycle (60–75% of cost in private).
Rwanda Dhont et al.
(2011)
Prospective evaluation of 244 fully investigated couples
including characteristics, diagnosis, recommended
treatment, and occurrence of pregnancy (spontaneous
and treatment related).
Infertility due to combined factors 50%, female factor 31%, male
factor 16%, unexplained 3%. After 12–18 months, 40 pregnancies
including 17 after hysterosalpingography and 9 after non-ART




Abels (2007) RCT comparing PRs after GIFT vs IUI with ovarian
stimulation in couples with unexplained infertility.
Higher ongoing PR after GIFT. Three oocytes per GIFT. Mean
number of cycles per pregnancy 7.3 (IUI) vs 2.0 (GIFT).
Bosman et al.
(2015)
Propsective observational study comparing ART
outcome in couples with hyperinsulinaemic and
normoinsulinaemic men (all normozoospermic).
Higher CPR/ET in normoinsulinaemic versus hyperinsulinaemic
group (57.9% vs 31.8%).
Dyer and Kruger
(2012)
Registry data. 4512 aspirations for IVF,ICSI and OD. CPR/asp 28.9%; 12.8%
SETsb and 54.5% DETsb. No data on FET, MPR, deliveries or births.
Dyer et al. (2013) Questionnaire-based interviews to determine extent and
impact of out-of-pocket payment for 1 ART cycle in a
government institution.
Out-of-pockey payment caused catastrophic expenditure for 22%
of all households and 51% of the poorest. Couples activated
multiple financial coping strategies. Mean annual CPR/ET ± 31%.
Raja and Franken
(2006)
Prospective evaluation of sperm morphometrics and
paternal sex chromosomes on ICSI outcome.
Sperm selection using morphometrics associated with good
fertilsation and PRs. Of 16 randomly selected embryos with no
development 68.7% were XY.
Windt et al.
(2002)
Retrospective evaulation of use of fresh, cryopreserved
and/or pre-incubated sperm on fertilisation and PRs
after ICSI/TESE.
Similar fertilisation and PRs in couples with obstructive vs non-
obstructive azoospermia. Preincubated sperm for associated with
similar ongoing PRs vs non-preincubation.
Asp, aspiration; CRP, clinical pregnancy rate; DET, double embryo transfer; FET, frozen embryo transfer; MPR, multiple pregnancy rate; No., number; OD, oocyte donation; OHSS,
ovarian hyperstimualtion syndrome; PCOS, polycystic ovary syndrome; PR, pregnancy rate; SET, single embryo transfer; TESE, testicular sperm extraction; USD, United States
Dollar; WHO, world health organization.
aNot adherent to PRISMA guidelines.
bNot presented as part of original study results but calculated from original study data for purpose of this review.
cClinical pregnancy defined as intrauterine pregnancy with foetal heart.
dTemporary infertility clinic in a research setting.
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to 4.2% per clinical pregnancy (Abels et al., 2007; Noreh et al., 2009;
Okohue et al., 2009; Orhue et al., 2012).The frequency of ovarian
hyperstimulation syndrome ranged widely, from 0.3% per initiated
cycle to 18.2% per woman with polycystic ovary syndrome, without
severity being specified (Noreh et al., 2009; Orhue et al., 2012;
Okohue et al., 2013). No information on aspiration related complica-
tions was identified.
Information on maternal and neonatal outcomes was similarly
scarce. Only one study provided reasonably comprehensive documen-
tation but based on a small sample size of 52 ART pregnancies (Ezechi
et al., 2008). Compared to >2000 spontaneous pregnancies, the
authors found statistically significant increases in early pregnancy
bleeding, placenta praevia, Caesarean sections, as well as rates of mul-
tiple pregnancy and preterm delivery. Differences remained significant
after controlling for confounding variables. Low preterm DRs were
reported in two other small samples but rising to 22.5% in a subgroup
of multiple pregnancies with a concomitant high rate of Caesarean
deliveries (Noreh et al., 2009; Orhue et al., 2012). Lastly, five papers
made reference to ART regulations. Ory et al. (2016) documented
absence of any form of government regulations in all the African coun-
tries participating in the IFFS Surveillance except South Africa. In the
absence of these, ART practice was frequently based on voluntary
adherence to international guidelines (Giwa-Osagie, 2002; Gerrits and
Shaw, 2010; Ory et al., 2016). Qualitative data captured the concern
that the global recognition for the need of regulation had not included
sub-Saharan Africa where lack of regulations hampered ART practice
and potentially exposed patients to substandard and costly care
(Murage et al., 2011; Ajayi and Dibosa-Osadolor, 2013).
Discussion
To our knowledge, this is the first review to systematically identify,
analyse and present published, peer-reviewed evidence on the avail-
ability, effectiveness and safety of ART in sub-Saharan Africa. Although
information on ART in Africa is captured at a global level by both the
IFFS Surveillance and ICMART World Report, our review focuses on
Africa while contributing additional information. It highlights what we
know – and all we do not.
There are 48 states in sub-Saharan Africa (https://data.worldbank.
org). Our review documented availability of ART in 10 of these of
which four provided papers included here. Services were delivered by
a total of 80 centres but this number missed data from Ghana, Sierra
Leone, Togo and Zimbabwe. Only six countries (Cameroon, Kenya,
Mali, Nigeria, Senegal and South Africa) participated in the IFFS
Surveillance and only three (Cameroon, Mali and South Africa) submit-
ted data to the latest ICMART world report (Dyer et al., 2016; Ory
et al., 2016). Collectively this implies that around 80% of African states
do not offer ART or do not reveal related information in the scientific
literature; and that the remaining countries publish little of their own
data and have low participation in global ART monitoring.
Our review highlights that the need for ART far exceeds what is
available and accessible. One thousand five hundred cycles per million
population per year are required to meet the need for ART, but in
2010 the regional mean for sub-Saharan Africa – albeit based on only
three countries – was 87 cycles/million (Collins, 2002; Dyer et al.,
2016). This was the lowest of all regions and less than one-fifth of glo-
bal utilization, which was reported as 474 cycles/million population. In
comparison, the mean utilization in Latin America was 152 (second
lowest), while Europe reported 932 cycles/million.
Unsurprisingly, this review identified cost as the single biggest bar-
rier. Underlying reasons are many and include the high prevalence of
poverty and low income in sub-Saharan African countries, the lack of
government or insurance scheme funding, the lack of resource alloca-
tion to capacity building (causing high expenditures for those acquiring
skills and infrastructure which need to be recuperated once ART is
being offered), and the lack of public sector infertility and ART ser-
vices. Other barriers included lack of services overall, outside large
urban settings, and for people not in heterosexual relationships; and
lack of patient education, public awareness, and acceptability of ART.
Our findings are in keeping with reports on access to health care,
which identify availability, affordability and acceptability as the key
determinants of access (Thiede and McIntyre, 2008; McIntyre et al.,
.............................................................................................................................................................................................





No. centres Annual no. aspirations (fresh
IVF and ICSI)
2016 Ory et al.
(2016)
6 Cameroon 2, Kenya 5, Mali 1, Nigeria 50, Senegal 2, South Africa 20 NA
2011 Murage et al.
(2011)
NA Kenya 3 NA
2010 Dyer et al.
(2016)




NA South Africa 18 4512 incl OD
2008 Ezechi et al.
(2008)
NA Nigeria 9 NA
2002 Giwa-Osagie
(2002)
7 Cameroon (NA), Ghana (NA), Nigeria (NA), Senegal (NA), South Africa
(NA), Togo (NA), Zimbabwe (NA)
NA
NA, not assessed; OD, oocyte donation.
aThe year to which reported availability pertains.
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2009). These authors emphasize that affordability has traditionally
dominated the concept of access to care, while acceptability of service
provision – for both users and providers – has received relatively little
attention. Moreover, even in Europe, where ART usage is high com-
pared to sub-Saharan Africa, cultural norms and values have been
shown to powerfully influence access to ART over and above country
wealth (Präg and Mills, 2017). Improving ART access thus does not
only require generating fiscal space for third party funding to improve
affordability – the difficulty of which is acknowledged and beyond the
scope of this discussion – but also must, for example, address repro-
ductive health illiteracy, societal attitudes and improving ART availabil-
ity through training and infrastructure development.
Half of the selected manuscripts provided information on ART
effectiveness. The predominant indicator was CPR per ET following
fresh IVF and ICSI, which ranged from 15% to 57%, with an average of
31.3% according to the ICMARTWorld Report in 2010. Internationally,
live birth – and preferably a single live birth at term – is considered the
most important indicator of ART success, although increasingly the
need to report cumulative live birth rates is recognized in view of the ris-
ing contribution from frozen ETs (Maheshwari et al., 2015). Our review
found almost no data on live births with even the ART registry in South
Africa failing to provide this information. Information on frozen ETs and
oocyte donation was similarly lacking. Collectively this implies that the
true success of ART is currently not documented.
.............................................................................................................................................................................................
Table IV Summary of clinical and multiple pregnancy rates.
Region/
Country
References Study population/Sample size Ovarian
stimulation






4619 fresh non-donor asp (Cameroon 96;
Mali 171; South Africa 4352)
Not specified CPR/asp 31.3% MBR 20% Cameroon, NA in
South Africa and Mali
Kenya Noreh et al.
(2009)
362 initiated fresh ART cycles Conventional Cumulative CPR 27.3%/
cycle(99/362)b
27.3% (27/99)b




9 couples treated with ART. Number of
cycles, asp or ET not specified
Not specified 77.8%/pt (7/9) 44.4% (4/9)
Ezechi et al.
(2008)
52 ART pregnancies Not specified NA 17.3% (9/52) vs 4.3% (93/
2160) (P < 0.05)2160 non-ART pregnancies
Melie (2003) 452 asp with ≥1 oocyte Conventional 19.7%/aspb (89/452) NA
421 fresh non-donor ETs 21.1%/ETb (89/421)
Okohue et al.
(2009)
298 women <36 y Conventional 39.0%/aspb (110/282) NA
276 fresh non-donor ETs 39.9%/ETb (110/276)
Okohue et al.
(2013)




55 ART multiple pregnancies Not specified NA 34.5% (19/55)c
Orhue et al.
(2012)
600 fresh non-donor ART cycles Conventional 30%/cycle (180/600) 20.0% (36/180)
35.7%/ET (180/504)504 fresh ETs
South
Africa








82 asp in women < 38 with ≥5 oocytes; 82
ETs
Conventional 43.9%/ETb (36/82) 38.9% (14/36)
Dyer and
Kruger (2012)
4512 aspd Not specified 28.9%/asp NA




39 couples requiring ICSI; no. cycles not
specified
Not specified PR 51.3%e/pt NA
Windt et al.
(2002)
142 ICSI asp with ≥1 oocyte; 135 ETs Conventional 18.3%/asp (26/142)b,f;
19.3%/ET (26/135)b,f
NA
PT, patient; uHMG, urinary HMG.
aDenominator: all clinical pregnancies.
bNot original study result but calculated from original data.
cSix triplets and two quadruplets.
dIncludes donor and non-donor cycles.
eNot clarified whether PR or CPR.
fDefined as intrauterine pregnancy with foetal heart.
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Multiple pregnancy is recognized as the leading risk of ART. Our
findings indicate a preference of transferring multiple embryos with
resultant multiple pregnancy rates of ±20–30%. Given the information
deficit on live births as well as obstetrical complications, this approach
to ‘optimizing’ ART success is unchallenged by any local evidence per-
taining to possible detrimental outcomes. The inverse relationship
between lack of third party funding and single ET is recognized and not
unique to sub-Saharan Africa (Chambers et al., 2014). Our review also
highlights the information deficit on ART-related maternal and neo-
natal complications, be it singleton or multiple pregnancies. How the
recognized complications of prematurity, low birthweight and opera-
tive deliveries impact on mothers and their offspring, how effectively
they are managed, and who carries the burden of their costs is there-
fore also unknown.
Strengths and limitations
The strength of this review lies in the pertinence and novelty of the
research question in sub-Saharan Africa, and in the rigorous process of
finding an answer. In addition, the authors had expertise in research
methodology and infertility in sub-Saharan Africa. The main limitation
was the broad definition of our outcome indicators. This resulted in
data that were both highly heterogeneous and that frequently contrib-
uted mere basics to the research question; for example, documenting
ART availability in terms of existing facilities rather than national, total
number of cycles. More stringent criteria might have improved data
quality but would have lessened the amount of information, which was
already scant. Data heterogeneity also prevented the combination or
comparison of data through statistical analysis let alone conduct a
meta-analysis. Manuscripts also lacked consistency in the definition of
clinical terms. The glossary for ART, recently revised and expanded,
provides international consensus definitions as an important prerequis-
ite for data collection, analysis and comparison (Zegers-Hochschild
et al., 2009, 2017): it was referenced by two manuscripts in this
review. Additional limitations include restricting the review to peer-
reviewed manuscripts with original data, and not attempting to contact
authors for primary data or further information. The decision to
exclude grey-literature, non-peer-reviewed manuscripts and opinion-
based papers attempted to generate a minimum of scientific homogen-
eity in otherwise diverse data.
Conclusion
While this systematic review provides best evidence on availability and
outcomes of ART in sub-Saharan Africa, it failed to adequately answer
the research question. This was due to the overall lack of data that are
generally accepted as being key components of evidence-based prac-
tice and development strategies. Evidently, such data need to be
derived from and be applicable to local settings. They cannot be extra-
polated from studies conducted in other parts of the world.
Fortunately, the need to close the ART information gap in sub-
Saharan Africa is increasingly recognized. Both regional and national fer-
tility organizations are calling for greater research output. Moreover, the
African Network and Registry for ART (ANARA; www.anara-africa.
com) has evolved over the last 3 years receiving support and recognition
from many stakeholders. Its mission is to collect, analyse and report
ART data at regional level while simultaneously providing participating
centres with confidential reports of their own data and countries with
their national data. ANARA was initiated under the auspices of
ICMART and received developmental support from the Latin American
Registry including donation of its data collection software. It is anticipated
that ANARA will build capacity in data collection, thereby addressing the
main limitation highlighted in this review. The ANARA-ICMART ini-
tiative has already resulted in increasing participation from African
countries in the ICMART World Reports, with two countries having
submitted 2009 data and seven countries 2012 data (Dyer et al.,
2016; ICMART, unpublished data). The collected data, which are
growing in width and depth, will strengthen our regional understand-
ing of the role of scientific data. It will then be the role of clinicians,
scientists, fertility organizations, governments and other stakeholders
to use the data for sound decision and policy-making.
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MeSH Keyword 
Reproductive Techniques, 
Assisted, and all 
subheadings 
Assisted Reproductive Techniques OR ART 
Assisted Reproductive Services OR ARS OR 
Assisted reproductive techniques outcome OR ART 
outcome OR assisted conception OR assisted 
reproduction OR infertility treatment OR infertility 
services OR infertility therapy OR fertility assistance 
OR assisted reproductive technologies OR frozen 
embryo transfer OR infertility management OR 
fertility assistance OR in vitro fertilization OR IVF OR 
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MeSH Keyword 
Developing countries, 
Africa south of Sahara 
Low-resource countries OR developing countries OR 
developing economies OR resource-constrained 
settings OR resource-poor countries OR Angola OR 
Benin OR Botswana OR Burkina Faso OR 
Cameroon OR Cape Verde OR Central African 
Republic OR Chad OR Comoros OR Congo 
Brazzaville OR Democratic Republic of Congo OR 
Cote d’Ivoire OR Djibouti OR Equatorial Guinea OR 
Eritrea OR Ethiopia OR Gabon OR Gambia OR 
Ghana OR Guinea OR Guinea-Bissau OR Kenya OR 
Lesotho OR Liberia OR Madagascar OR Malawi OR 
Mauritania OR Mauritius OR Mozambique OR 
Namibia OR Niger OR Reunion OR Rwanda OR Sao 
Tome OR Sao Principe OR Senegal OR Seychelles 
OR Sierra Leone OR Somalia OR South Africa OR 
Sudan OR Swaziland OR Tanzania OR Togo OR 
Uganda OR Western Sahara OR Zambia OR 
Zimbabwe 
 Availability OR effectiveness OR safety OR risks OR 
efficacy 
 Years: 2000-2016 
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2. Data extraction and critical appraisal tool 
Author      
Year      
Journal      
Study type      
Title      
 Clearly focused research question  
      
Abstract      
 Structured summary of    
  Study design   
  Methods    
  Results    
  Conclusions   
Introduction      
 Problem definition    
 
Describe the rationale for the review/study in the context of what is already 
known   
 Provide an explicit statement of questions being addressed with reference to  
  Participants   
  Study population   
  Interventions   
  Comparisons   
  Outcomes   
  Study design   
      
Method      
 Does the research design answer the question  
      
 Systematic review    
  Does a registered review protocol exist  
  Clear inclusion exclusion criteria for papers stated  
   Dates searched  
   Databases searched  
   Literature/study type searched  
   Language   
  Search strategy available in sufficient detail to be repeated  
  Was method of data extraction described  
  Was risk of bias in individual studies assessed  
  Described method of data handling  
  Risk of bias identified  
  Precautions taken to eliminate risk of bias  
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  Describe how missing data was handled  
      
 Randomised control trials    
  Described trial design (such as parallel or factorial)  
  Described allocation ratio  
  Clearly stated eligibility criteria   
  Clearly defined difference between two groups  
  
The interventions for each group described in sufficient details to 
allow replication  
  Completely defined outcomes  
   Primary    
   Secondary  
  Any changes in outcomes during trial  
  Mention of how sample size determined  
  Randomisation    
   Type    
   Described method used for randomisation   
   
Described any steps taken to conceal the sequence of 
allocation  
  Blinding described in detail  
  
Statistical methods used to compare groups for primary and 
secondary outcomes described  
  Assessment of study quality  
   Power calculations done  
   Bias   
   Limitations of study addressed  
  Describe how missing data was handled  
      
 
Observational 
studies    
  Described adequately  
   Setting   
   Dates of recruitment/exposure  
   Methods of follow-up  
   Diagnostic method  
  Clearly stated eligibility criteria  
  Clearly defined outcomes  
   Primary    
   Secondary  
  Clearly defined confounding factors  
  Details of methods of assessment for each variable of interest given   
  Efforts to address potential sources of bias mentioned  
  Explain how the study size was arrived at  
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  Was missing data was addressed  
  Was loss to follow up addressed  
  Cases and controls assignment described  
      
Results      
 Systematic review    
  Information flow described adequately  
   Flow diagram included  
  Results from individual studies presented  
  Presented results of any assessment of risk of bias across studies   
      
 Randomised control trial   
  
Each group received intended treatment and were analysed for the 
primary outcome  
  Each group were analysed for the primary outcome  
  Losses and exclusions after randomisation reported  
  Baseline demographic and clinical characteristics for each group  
  Results for each group  
   Primary outcome  
   Secondary outcome  
   Precision (such as 95% confidence interval)   
   All important harms or unintended effects   
  Reported numbers of individuals at each stage of study  
  Reasons for non-participation given   
  Indicate missing data for each variable of interest  
  All participants accounted for   
   If not Lost to follow up  
    Not included  
      
 
Observational 
studies    
  Reported numbers of individuals at each stage of study  
  Reasons for non-participation given   
  Indicate missing data for each variable of interest  
  Baseline demographic and clinical characteristics for each group  
  Gave confounder adjusted estimates (eg 95% confidence interval)  
  Performed sensitivity testing  
  All outcomes reported for   
  All participants accounted for   
   If not Lost to follow up  
    Not included  
      
Discussion Summarise key results with reference to study objectives   
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  Sources of potential bias  
  Statistical uncertainty  
  Generalisability   
 
Implications for practice, including the intended use and clinical role of the index 
test  
 
Summarize the main findings including the strength of evidence for each main 
outcome  
 Provide a general interpretation of the results in the context of other evidence  
 Provide implications for future research   
 Consideration of alternative explanations for observed results   
      
Other Ethical issues considered   
 Sources of funding and other support; role of funders   
      
Sample size      
Population      
Outcomes      
 Safety     
 
Mention 
of Number of embryos transferred  
  Multiple pregnancy rate  
  Ectopic pregnancy rate  
  Ovarian hyperstimulation syndrome  
  Infection    
  Bleeding    
  Pregnancy complications  
   Maternal    
   Fetal   
 Availability     
 
Mention 
of Referral to ART centre  
   Private    
   Public   
  Unmet need for ART service  
   Partial    
   Complete  
  Unable to afford ART  
  Number of ART centres  
  Number of ART cycles performed  
 Effectiveness    
 
Mention 
of  Pregnancy rate   
  Live birth rate   
  Delivery rate   
 
